Please create a high-level masters level PowerPoint (12 slides) with speaker notes on each slide for the following 2 questions Please comment on the following questions: 1. What are some of the...

Running Head: PowerPoint Presentation     1
PowerPoint Presentation                         2
POWERPOINT PRESENTATION
Table of Contents
Slide 1: Introduction    3
Slide 2: Challenges in managing and creating contracts and grants    3
Slide 3: Registration    3
Slide 4: Registration (Continue)    4
Slide 5: Reporting    4
Slide 6: Reporting (Continue)    5
Slide 7: Ineffective and unsustainable compliance monitoring    5
Slide 8: Ineffective and unsustainable compliance monitoring (Continue)    6
Slide 9: Sharing Data    6
Slide 10: Strategies to use    6
Slide 11: Strategies to use (Continue)    7
Slide 12: Strategies to use (Continue)    7
Slide 13: References    9
Slide 1: Introduction
· Title
Slide 2: Challenges in managing and creating contracts and grants
· Researchers need registered trails
· Reporting results to the funders
· Ineffective and unsustainable compliance monitoring
· Sharing data
Only half of the clinical trials that the Medical Research Council (MRC) financed between 2011 and 2017 were registered in the WHO main registry, which was clearly mentioned in MRC grant terms (AAMCtoday). This highlights the importance of continued collaborative efforts to eliminate impediments to timely publishing, contracting, and reporting. Additionally, things were noted, such as if results were unfavourable or publication delays following an early study termination.
Slide 3: Registration
· Trials must be entered in the ISRCTN registry for researchers receiving MRC funding.
· The reduction in the percentage of trials recorded retroactively was a significant positive finding.
· To increase the quality and consistency of trial records and to get funding, registries should examine existing procedures and guidelines around data input by researchers.
Trial registration in the ISRCTN registry, a WHO primary registry and a regular contributor to the ICTRP11's goal of enhancing access to trial information, is a requirement for MRC-funded researchers (AAMCtoday). Researchers are required by MRC policy to add trial protocols and publications in addition to periodically reviewing and updating registry entries, contracts, and funding to verify their accuracy. The proportion of trials that registered retrospectively decreased, which was a significant positive outcome. This trend was linked to researchers' growing knowledge of the need of registering their trials (Wake health).
Slide 4: Registration (Continue)
· Studies listed with the MRC were not listed in the ISRCTN registry.
· Preventing participants from receiving comprehensive and accurate information.
· Organizations and sponsors should assume more accountability for overseeing and fostering transparency.
Many of the clinical studies listed with the MRC were not listed in the ISRCTN registry, which prevented participants from receiving comprehensive and accurate information about their trials. Despite early protocol release being essential to minimizing selective reporting and publication bias of trial data, only one-third of registry entries had a link to the trial protocol. They wholeheartedly concur with the demand made by Zou et al. (2019)those trial organizations and...